Tradestie Institutional Equity Comparison Engine
TCMD vs MYO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TCMD Overall Edge
TCMD Captures Institutional Edge (4โ0 Pillars ยท 8โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tactile Systems Technology, Inc. (TCMD) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, TCMD trades at 17.4x Forward P/E with 9.4% operating margin (+7.1% YoY revenue) versus MYO at N/M Forward P/E and -21.8% operating margin (+22.2% YoY). In options structure, TCMD sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro) against MYO sits in UNCLASSIFIED (81st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
TCMD
TCMD 17.4x vs MYO N/M Fwd P/E
Growth & Margin Winner
TCMD
Op Margin 9.4% vs -21.8% ยท YoY +7.1% vs +22.2%
Momentum & Technical Winner
TCMD
1Y +5.7% vs +12.3% ยท 52W Pos 29% vs 16%
Options & Structure Winner
TCMD
CONSOLIDATION (15th %ile IV) vs UNCLASSIFIED (81st %ile IV)
TCMD
NASDAQ
Tactile Systems Technology, Inc.
Surgical & Medical Instruments & Apparatus
$25.60
-1.5% 1D
Market Cap
$582.2M
1M Return
+8.75%
1Y Return
+5.65%
Forward P/E
17.4x
Unified AI Score
40.1 / 100
SELL
Tech 37.0
Fund 44.0
Flow 65.0
Mom 31.1
MYO
NYSE American
Myomo Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.81
-3.45% 1D
Market Cap
$33.7M
1M Return
-33.52%
1Y Return
+12.3%
Forward P/E
N/M
Unified AI Score
40.1 / 100
SELL
Tech 25.0
Fund 43.0
Flow 58.0
Mom 59.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
TCMD +5.65%
MYO +12.3%
Spread: +6.65 pp (MYO Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | TCMD Revenue | MYO Revenue | TCMD Op. Margin | MYO Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $140M | $0M | 2.1% | -430.8% | TCMD |
| FY2019 | $190M | $0M | 5.5% | -281.3% | TCMD |
| FY2020 | $190M | $10M | -1.9% | -138.5% | TCMD |
| FY2021 | $210M | $10M | -0.8% | -74.1% | TCMD |
| FY2022 | $250M | $20M | -5.2% | -68.6% | TCMD |
| FY2023 | $270M | $20M | 6.6% | -42.8% | TCMD |
| FY2024 | $290M | $30M | 7.6% | -19.1% | TCMD |
| FY2025 | $330M | $40M | 8.9% | -35.2% | TCMD |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TCMD | MYO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $582.2M | $33.7M | Larger Scale | TCMD |
| Trailing P/E Ratio Valuation | 25.2x | N/M | Lower Multiple | TCMD |
| Forward P/E Ratio Valuation | 17.4x | N/M | Lower Multiple | TCMD |
| Revenue Growth (YoY) Growth | +7.1% | +22.2% | Higher Growth | MYO |
| Operating Margin (TTM) Profitability | 9.4% | -21.8% | Higher Margin | TCMD |
| Net Profit Margin Profitability | 6.7% | -33.1% | Higher Margin | TCMD |
| Return on Equity (ROE) Capital Efficiency | 11.0% | -173.5% | Higher ROE | TCMD |
| 52-Week Range Position Momentum | 29% ($21โ$38) | 16% ($1โ$2) | Stronger Trend | TCMD |
| Beta / 30D Volatility Risk Regime | 0.95ฮฒ ยท 52% Vol | 2.22ฮฒ ยท 107% Vol | Lower Realized Risk | TCMD |
| Unified Institutional Score Composite Signal | 40.1 / 100 (SELL) | 40.1 / 100 (SELL) | Higher Composite | Tie |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full TCMD vs MYO Buy Guide
TCMD
CONSOLIDATION
98d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
15th %ile
IV Regime
Compressed (<25th %ile)
MYO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
81st %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither TCMD nor MYO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.